These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2885888)

  • 1. Self-perception of tardive dyskinesia and neuroleptic-induced parkinsonism: a study of clinical correlates.
    Lohr JB; Lohr MA; Wasli E; Hilliard B; Larson L; Vardiman E; Wade L; Jeste DV
    Psychopharmacol Bull; 1987; 23(1):211-4. PubMed ID: 2885888
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroleptic-induced tardive dyskinesia and parkinsonism: changes during several years of continuing treatment.
    Casey DE; Povlsen UJ; Meidahl B; Gerlach J
    Psychopharmacol Bull; 1986; 22(1):250-3. PubMed ID: 2873612
    [No Abstract]   [Full Text] [Related]  

  • 3. Drug-induced parkinsonism and tardive dyskinesia in nonpsychiatric patients.
    Grimes JD
    Can Med Assoc J; 1982 Mar; 126(5):468. PubMed ID: 6121618
    [No Abstract]   [Full Text] [Related]  

  • 4. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia.
    Barnes TR; Liddle PF; Curson DA; Patel M
    Br J Psychiatry Suppl; 1989 Nov; (7):99-103. PubMed ID: 2575915
    [No Abstract]   [Full Text] [Related]  

  • 5. Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
    Bitton V; Melamed E
    J Clin Psychiatry; 1984 Jan; 45(1):28-30. PubMed ID: 6141157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical association of tardive dyskinesia and drug-induced parkinsonism.
    Wolf ME; Chevesich J; Lehrer E; Mosnaim AD
    Biol Psychiatry; 1983 Oct; 18(10):1181-8. PubMed ID: 6140032
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk factors for drug-induced parkinsonism in tardive dyskinesia patients.
    Hansen TE; Brown WL; Weigel RM; Casey DE
    J Clin Psychiatry; 1988 Apr; 49(4):139-41. PubMed ID: 2895762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State-dependent tardive dyskinesia in manic-depressive illness.
    de Potter RW; Linkowski P; Mendlewicz J
    J Neurol Neurosurg Psychiatry; 1983 Jul; 46(7):666-8. PubMed ID: 6136551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbidopa/levodopa therapy of coexistent drug-induced parkinsonism and tardive dyskinesia.
    Shoulson I
    Adv Neurol; 1983; 37():259-66. PubMed ID: 6134445
    [No Abstract]   [Full Text] [Related]  

  • 10. [Tardive dyskinesias].
    Mignot G
    Encephale; 1983; 9(2):151-66. PubMed ID: 6139271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone-induced tardive dyskinesia and parkinsonism.
    Gwinn KA; Caviness JN
    Mov Disord; 1997 Jan; 12(1):119-21. PubMed ID: 8990067
    [No Abstract]   [Full Text] [Related]  

  • 12. Movement disorders with neuroleptic drug treatment.
    Tarsy D
    Psychiatr Clin North Am; 1984 Sep; 7(3):453-71. PubMed ID: 6148742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiapride in the treatment of tardive dyskinesia: a clinical and biochemical study.
    Perényi A; Arató M; Bagdy G; Frecska E; Szücs R
    J Clin Psychiatry; 1985 Jun; 46(6):229-31. PubMed ID: 2860098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A five year follow-up study of tardive dyskinesia.
    Chouinard G; Annable L; Mercier P; Ross-Chouinard A
    Psychopharmacol Bull; 1986; 22(1):259-63. PubMed ID: 2873614
    [No Abstract]   [Full Text] [Related]  

  • 15. The psychological consequences of tardive dyskinesia. The effect of drug-induced parkinsonism and the topography of the dyskinetic movements.
    Brown KW; White T
    Br J Psychiatry; 1991 Sep; 159():399-403. PubMed ID: 1683594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Episodic tardive dyskinesia and parkinsonism in bipolar disorder patients.
    Scappa S; Teverbaugh P; Ananth J
    Can J Psychiatry; 1993 Dec; 38(10):633-4. PubMed ID: 7906192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of neuroleptic-induced dyskinesia and parkinsonism: the influence of measurement methods and definitions.
    Dean CE; Kuskowski MA; Caligiuri MP
    J Clin Psychopharmacol; 2006 Dec; 26(6):560-5. PubMed ID: 17110811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)].
    Arushanian EB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):269-77. PubMed ID: 2858951
    [No Abstract]   [Full Text] [Related]  

  • 19. Tardive dyskinesia, mild drug-induced dyskinesia, and drug-induced parkinsonism: risk factors and topographic distribution.
    Akbostanci MC; Atbaşoğlu EC; Balaban H
    Acta Neurol Belg; 1999 Sep; 99(3):176-81. PubMed ID: 10544725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of neuroleptic-induced parkinsonism in psychotic patients receiving adjunctive electroconvulsive therapy.
    Mukherjee S; Debsikdar V
    Convuls Ther; 1994 Mar; 10(1):53-8. PubMed ID: 7914462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.